Establishment Labs Holdings (ESTA) Non-Current Debt (2017 - 2026)
Establishment Labs Holdings' (ESTA) quarterly Non-Current Debt came in at $248.6 million in Q1 2026, up 12.82% year-on-year from $220.3 million in Q1 2025, and little changed quarter-over-quarter from $247.5 million in Q4 2025.
Establishment Labs Holdings (ESTA) Non-Current Debt (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Non-Current Debt history runs 10 years deep, the most recent figure standing at $248.6 million for Q1 2026.
- On a quarterly basis, Non-Current Debt rose 12.82% year-over-year to $248.6 million in Q1 2026; TTM through Mar 2026 was $248.6 million, a 12.82% increase from a year earlier, with the FY2025 full-year figure at $247.5 million, up 12.73% from the prior year.
- Non-Current Debt steadied at $248.6 million in Q1 2026 per ESTA's latest filing, from $247.5 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $248.6 million in Q1 2026 and bottomed at $52.5 million in Q1 2022.
- The 5-year median for Non-Current Debt is $193.0 million (2024), against an average of $193.3 million.
- Across the five-year window, Non-Current Debt increased 4.34% in 2022 and surged 240.37% in 2023, its largest moves.
- Year by year, Non-Current Debt stood at $175.5 million in 2022, then climbed by 7.57% to $188.7 million in 2023, then gained by 16.34% to $219.6 million in 2024, then increased by 12.73% to $247.5 million in 2025, then grew by 0.43% to $248.6 million in 2026.
- Per Business Quant, the three latest ESTA Non-Current Debt figures stand at $248.6 million (Q1 2026), $247.5 million (Q4 2025), and $246.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.18 Bn |
| 10 | Establishment Labs Holdings | 2.73 Bn | 2.66 Bn | 42.34 Mn | 248.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 248.59 Mn |
| Dec 31, 2025 | 247.52 Mn |
| Sep 30, 2025 | 246.46 Mn |
| Jun 30, 2025 | 221.13 Mn |
| Mar 31, 2025 | 220.34 Mn |
| Dec 31, 2024 | 219.58 Mn |
| Sep 30, 2024 | 194.36 Mn |
| Jun 30, 2024 | 193.73 Mn |
| Mar 31, 2024 | 192.19 Mn |
| Dec 31, 2023 | 188.74 Mn |
| Sep 30, 2023 | 185.32 Mn |
| Jun 30, 2023 | 181.97 Mn |
| Mar 31, 2023 | 178.65 Mn |
| Dec 31, 2022 | 175.46 Mn |
| Jun 30, 2022 | 145.48 Mn |
| Mar 31, 2022 | 52.49 Mn |
| Dec 31, 2021 | 51.91 Mn |
| Sep 30, 2021 | 51.34 Mn |
| Jun 30, 2021 | 50.81 Mn |
| Mar 31, 2021 | 50.31 Mn |